Focused update on the new ESC Guidelines on atrial fibrillation: focus on the new recommendations for anti-arrhythmic drugs

Watch the webinar recording

The ESC Webinar are designed to help you improve your daily practice!
The format includes a case based presentation, online assesssment and live discussions with the two key opinion leaders who will deliver useful tips for your daily clinical practice.

• To understand the selection of patients for therapy with anticoagulant drugs, and alternative antithrombotic strategies
• To understand the use of vitamin K antagonists and novel oral anticoagulants, particularly dabigatran and rivaroxaban
• To be aware of the specific indications for pharmacological cardioversion with antiarrhythmic agents
• To appreciate the changed indications and monitoring for treatment with dronedarone.
• To learn about new indications for left atrial catheter ablation for management of recurrent forms of atrial fibrillation

2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation.
Developed with the special contribution of the European Heart Rhythm Association.
Europace. 2012 Aug 24. [Epub ahead of print] PubMed PMID: 22923145